Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection

Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection

Abstract Background The rapid global emergence and spread of carbapenem-resistant Gram-negative bacilli (CR-GNB) is recognized as a major public health concern, and there are currently few effective treatments for CR-GNB infection. The aim of this study was to investigate the clinical characteristic...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Zihao Zheng, Ziqiang Shao, Lihai Lu, Siyu Tang, Kai Shi, Fangxiao Gong, Jingquan Liu
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: BMC 2023-10-01
Sarja:BMC Infectious Diseases
Aiheet:
Ceftazidime/avibactam
Colistin
Combination therapy
Carbapenem-resistant Gram-negative bacilli
Linkit:https://doi.org/10.1186/s12879-023-08715-w

Internet

https://doi.org/10.1186/s12879-023-08715-w

Samankaltaisia teoksia